Author

A. Stafford

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cancer & tumor microenvironment· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

D. J. Mooney· 3 shared K. Adu-Berchie· 2 shared M. O. Dellacherie· 2 shared A. Chumber· 1 shared A. J. Najibi· 1 shared A. Li· 1 shared A. Najibi· 1 shared B. R. Seo· 1 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. J. Mooney

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Enhancing adoptive T cell therapy with synergistic host immune engagement promotes long-term protection against solid tumors

K. Adu-Berchie, J. M. Brockman, Y. Liu, D. K. Y. Zhang, A. J. Najibi, A. Stafford, M. C. Sobral, Y. Binenbaum, M. O. Dellacherie, D. J. Mooney

This paper presents a biomaterial platform that enhances adoptive T cell therapy by engaging the host immune system, leading to better tumor control and long-term protection against solid tumors.

bioRxiv · Sep 10, 2022 · PreprintImmunology

STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models

G. Berger, E. H. Knelson, J. L. Jimenez-Macias, M. O. Nowicki, S. Han, P. H. Lizotte, K. Adu-Berchie, A. Stafford, N. Dimitrikakis, E. A. Chiocca, D. J. Mooney, D. A. Barbie, S. E. Lawler

This study shows that STING activation in glioblastoma models enhances immune responses and NK cell-mediated tumor regression, with long-term survival benefits in murine models.

bioRxiv · Feb 28, 2022 · PreprintCancer Biology

Immune-responsive biodegradable scaffolds for enhancing neutrophil regeneration

M. Kerr, D. McBride, W. Johnson, A. Chumber, A. Najibi, B. R. Seo, A. Stafford, D. Scadden, D. Mooney, N. Shah

This study develops a biodegradable HA cryogel scaffold that degrades in response to neutrophils, enhancing neutrophil recovery post-HSCT and accelerating cryogel degradation.

bioRxiv · Jan 21, 2022Bioengineering

Single-shot Mesoporous Silica Rods Scaffold for Induction of Humoral Responses Against Small Antigens

M. O. Dellacherie, A. Li, B. Y. Lu, C. S. Verbeke, L. Gu, A. Stafford, E. J. Doherty, D. J. Mooney

This study demonstrates that a single injection of mesoporous silica rods (MSRs) vaccine can generate potent and durable humoral immunity against small antigens like GnRH and Her2/neu peptides.

bioRxiv · Mar 17, 2020Bioengineering